Sangamo Therapeutics
SGMO
#10399
Rank
NZ$53.95 M
Marketcap
NZ$0.13
Share price
0.00%
Change (1 day)
-84.55%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -NZ$0.19 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are NZ$32.87 Million. In 2024 the company made an earning of -NZ$0.18 Billion, an increase over its 2023 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.19 Billion9.07%
2024 -NZ$0.18 Billion-17.27%
2023 -NZ$0.21 Billion-40.88%
2022 -NZ$0.36 Billion9.79%
2021 -NZ$0.33 Billion41.52%
2020 -NZ$0.23 Billion23.17%
2019 -NZ$0.19 Billion36.33%
2018 -NZ$0.14 Billion36.89%
2017 -NZ$99.2 Million-22.32%
2016 -NZ$0.13 Billion54.86%
2015 -NZ$82.47 Million75.62%
2014 -NZ$46.96 Million0.13%
2013 -NZ$46.9 Million
2011 -NZ$63.05 Million43.66%
2010 -NZ$43.89 Million28.52%
2009 -NZ$34.15 Million-23.55%
2008 -NZ$44.67 Million2.45%
2007 -NZ$43.6 Million19.5%
2006 -NZ$36.49 Million50.78%
2005 -NZ$24.2 Million75%
2004 -NZ$13.83 Million-33.25%
2003 -NZ$20.72 Million-62.27%
2002 -NZ$54.91 Million102.82%
2001 -NZ$27.07 Million23.21%
2000 -NZ$21.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.72 B-23,928.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.99 B-8,434.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.85 B-1,588.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-NZ$4.45 Billion 2,217.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.24 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$23.14 B-12,163.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$1.53 B-897.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.67 B-453.67%๐Ÿ‡บ๐Ÿ‡ธ USA